Representative Elijah Cummings excoriated Mylan in his opening remarks at Wednesday's congressional hearing about EpiPen prices.
“This hearing is critical because yet another drug company, Mylan, has jacked up the price of a lifesaving product for no discernible reason — and I did read your testimony, Ms. Bresch, and I was not impressed,” Cummnings said. “The reason being, I believe, is to get filthy rich at the expense of our constituents.”
Bresch in her testimony focused on the efforts the company has made to increase availability of the devices, but did not give a reason for the increase in price.
Read Full Article »